PAtient NOtifier Feature for Reduction of Anxiety (Panoramic)
This study has been completed.
Sponsor:
St. Jude Medical
Information provided by:
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT00559559
First received: November 15, 2007
Last updated: July 12, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is intended to look at the effect of the SJM vibrating Patient Notifier™ system, which will warn the patient of possible failures of the implanted system, on reducing patient device related anxiety
| Condition | Intervention |
|---|---|
|
Tachycardia, Ventricular |
Device: ICD implant + Patient Notifier turned OFF Procedure: ICD Implant + Patient Notifier turned ON |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | PAtient NOtifier Feature for Reduction of Anxiety: A Multicenter ICD Study |
Resource links provided by NLM:
Further study details as provided by St. Jude Medical:
Primary Outcome Measures:
- Reduction in device related anxiety, related to battery depletion, as assessed by the Duru Questionnaire (question 9) Reduction in device related anxiety, related to device malfunction, as assessed by the Duru Questionnaire (question 10) [ Time Frame: 12months ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Reduction in general anxiety Evolution over time in anxiety for the different personality types Cross-overs Sensitivity and Specificity of the Patient Notifier™ Number of appropriate/inappropriate ICD therapies Hospitalizations Mortality [ Time Frame: 1year ] [ Designated as safety issue: Yes ]
| Enrollment: | 362 |
| Study Start Date: | December 2007 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Control Group
Patient Notifier turned OFF
|
Device: ICD implant + Patient Notifier turned OFF
ICD implant, plus standard care, i.e. Patient Notifier turned off
|
|
Experimental: Treatment group
Patient Notifier turned ON
|
Procedure: ICD Implant + Patient Notifier turned ON
ICD implant. The Patient Notifier™ feature will be turned ON.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patient has recently (min. 2 weeks - max. 14 weeks) been implanted with an SJM ICD with the Patient Notifier™ feature;
- Patient is willing and able to independently comprehend and complete the study-related questionnaires;
- Patient has signed the study specific informed consent form.
Exclusion Criteria:
- have already had a Patient Notifier™ alert since implant;
- had a prior device implant (PM or ICD);
- have not been discharged from the hospital since device implant;
- have evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records;
- cannot commit to the follow-up schedule;
- have a life expectancy of less than 1 year;
- are on a waiting list for a heart transplant;
- are less than 18 years old;
- are pregnant;
Contacts and Locations
More Information
No publications provided by St. Jude Medical
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Christophe Bailleul, St. Jude Medical |
| ClinicalTrials.gov Identifier: | NCT00559559 History of Changes |
| Other Study ID Numbers: | CR06002HV |
| Study First Received: | November 15, 2007 |
| Last Updated: | July 12, 2011 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by St. Jude Medical:
|
Primary and secondary prevention for ventricular tachycardia |
Additional relevant MeSH terms:
|
Tachycardia Tachycardia, Ventricular Arrhythmias, Cardiac |
Heart Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 22, 2013